Center Book Partners LP Humacyte, Inc. Call Options Transaction History
Center Book Partners LP
- $1.7 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HUMA
# of Institutions
170Shares Held
54.4MCall Options Held
1.1MPut Options Held
808K-
Black Rock Inc. New York, NY7.14MShares$13.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$13.2 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$8.26 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$5.54 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.64MShares$4.96 Million0.01% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $194M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...